Simon will be a panelist for the session, “Compliance Challenges in India: Why Your Compliance Program May Not Translate.” The discussion will focus on the following topics and trends:
- Some policies and procedures global companies deploy in the rest of the world likely will not be effective in India. India-specific opportunities include due diligence, training and G&E thresholds that impact effective E&C implementation.
- What unique challenges are posed by the legal and enforcement landscape in India? Consider enforcement trends that foreign companies need to note and the unique role criminal law plays in commercial disputes.
- How can challenges for US based in-house professionals and outside lawyers conducting internal investigations in India be mitigated? Reflect on cultural, legal and practical implications of conducting cross border work.
For more information or to register, visit the event website.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.